A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : eCB / endocannabinoid

[Related PubMed/MEDLINE]
Total Number of Papers: 370
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   eCB  (>> Co-occurring Abbreviation)
Long Form:   endocannabinoid
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Activation of tyrosine phosphatase PTP1B in pyramidal neurons impairs endocannabinoid signaling by tyrosine receptor kinase trkB and causes schizophrenia-like behaviors in mice. ---
2020 Alterations of brain endocannabinoidome signaling in germ-free mice. 2-AG, AEA, eCBome, FMT, GF, NAEs
2020 Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy. AEA, BLA, FAAH
2020 Antidepressant-like effects of URB597 and JZL184 in male and female rats exposed to early life stress. BDNF, ELS, FAAH, MAGL, NAc
2020 BDNF Controls Bidirectional Endocannabinoid Plasticity at Corticostriatal Synapses. BDNF, TrkB
2020 Calcium-Permeable AMPA Receptors Promote Endocannabinoid Signaling at Parvalbumin Interneuron Synapses in the Nucleus Accumbens Core. CB1, LTD, MSNs, NAc, PV
2020 Cannabinoids as therapeutics for PTSD. HPA, PTSD
2020 Cannabinoids for People with ASD: A Systematic Review of Published and Ongoing Studies. ASD, CBD
2020 CB1 cannabinoid receptor-mediated plasticity of GABAergic synapses in the mouse insular cortex. CB1Rs, HFS, LTP, LTPGABA, NO
10  2020 Circadian Misalignment of the 24-hour Profile of Endocannabinoid 2-Arachidonoylglycerol (2-AG) in Obese Adults. 2-AG, 2-OG, BMI
11  2020 Circulating Endocannabinoids and Mortality in Hemodialysis Patients. 2-AG, AEA, ESRD, HR, MHD
12  2020 Colonization with the commensal fungus Candida albicans perturbs the gut-brain axis through dysregulation of endocannabinoid signaling. AEA, CORT, FAAH, GI, HPA
13  2020 Components of Endocannabinoid Signaling System Are Expressed in the Perinatal Mouse Cerebellum and Required for Its Normal Development. 2-AG, CB1, CB1-KO
14  2020 Diacylglycerol lipase alpha in astrocytes is involved in maternal care and affective behaviors. 2-AG, DAGLa
15  2020 Differential effect of Interferon-alpha treatment on AEA and 2-AG levels. 2-AG, AEA, eCBs, END, FU, HCV, IFN-alpha, IL, TW
16  2020 Effects of the monoacylglycerol lipase inhibitor JZL184 on chickens infected with avian pathogenic Escherichia coli O78: A preliminary pharmacokinetic and infection study. APEC, BW, MAGL
17  2020 Endocannabinoid hydrolysis inhibition unmasks that unsaturated fatty acids induce a robust biosynthesis of 2-arachidonoyl-glycerol and its congeners in human myeloid leukocytes. 2-AG, AA, GPCR, LPA, MAGs, UFAs
18  2020 Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder. FAAH, NSF, PTSD, WE
19  2020 Endocannabinoid Modulation of Microglial Phenotypes in Neuropathology. CB2R
20  2020 Endocannabinoid signaling as an intrinsic component of the circuits mediating adaptive responses to repeated stress exposure in adult male sprague dawley rats. CB1, CORT, HPA
21  2020 Endocannabinoids mediate long-lasting behavioural and physiological changes in male rats induced by the repeated activation of the mesolimbic system by copulation to satiety. DA, NAcc, VTA
22  2020 High-intensity swimming exercise reduces inflammatory pain in mice by activation of the endocannabinoid system. CFA, FAAH, HISE, i.p, i.pl, i.t, MAGL
23  2020 Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes. ---
24  2020 hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation. CBD, CNS, Delta9-THC, hiPSC, SCs
25  2020 HIV Tat Protein Selectively Impairs CB1 Receptor-Mediated Presynaptic Inhibition at Excitatory But Not Inhibitory Synapses. 2-AG, CB1R, Delta9-THC, DSE, HAND, Tat
27  2020 Impact of a weight loss and fitness intervention on exercise-associated plasma oxylipin patterns in obese, insulin-resistant, sedentary women. HETE, LOX, OxL, PUFA
28  2020 Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide). 2-AG, OEA, PEA
29  2020 Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice. CB1, DG-ML, DID, EtOH, fEPSPs, MAGL, MPP
30  2020 Kinesin-1-mediated axonal transport of CB1 receptors is required for cannabinoid-dependent axonal growth and guidance. CB1R
31  2020 Lights on Endocannabinoid-Mediated Synaptic Potentiation. CB1Rs, eCB-LTP
32  2020 Obesity Affects the Microbiota-Gut-Brain Axis and the Regulation Thereof by Endocannabinoids and Related Mediators. HFDs, IL-1 beta, LPS, TNF-alpha
33  2020 Prefrontal Cortex Neuromodulation Enhances Frontal Asymmetry and Reduces Caloric Intake in Patients with Morbid Obesity. CT, DLPFC, EEG, FC, tDCS
34  2020 Role of the endocannabinoid system in the regulation of the skeletal muscle response to exercise. eCBs, ECS, T2D
35  2020 Role of the stress response and the endocannabinoid system in Delta9-tetrahydrocannabinol (THC)-induced nausea. 2-AG, AEA, CHS, CORT, CRH, HPA, THC
36  2020 Spatio-temporal effects of acute alcohol intoxication on endocannabinoid system in rat brain and blood. ECS
37  2020 Stress-induced modulation of endocannabinoid signaling leads to delayed strengthening of synaptic connectivity in the amygdala. AEA, BLA, FAAH, mEPSCs
38  2020 Synthesis and Preliminary Evaluation of a Novel Positron Emission Tomography (PET) Ligand for Imaging Fatty Acid Amide Hydrolase (FAAH). AEA, CNS, FAAH, PET
39  2020 Targeting the inhibition of fatty acid amide hydrolase ameliorate the endocannabinoid-mediated synaptic dysfunction in a valproic acid-induced rat model of Autism. AEA, AMPARs, ASD, eCB-LTD, mGluR, mGluR-LTD, PFC, VPA
40  2020 Termination of acute stress response by the endocannabinoid system is regulated through lysine-specific demethylase 1-mediated transcriptional repression of 2-AG hydrolases ABHD6 and MAGL. 2-AG, ABHD6, CB1, ECS, LSD1, MAGL
41  2020 The Endocannabinoid System Contributes to Memory Deficits Induced by Rapid-eye-movement Sleep Deprivation in Adolescent Mice. 2-AG, CB1R, DSI, REMSD
42  2019 2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity. 2-AG, 2-LG, AEA, CB1, CB2
43  2019 ABHD6: Its Place in Endocannabinoid Signaling and Beyond. ABHD6
44  2019 Acute and chronic modulation of striatal endocannabinoid-mediated plasticity by nicotine. eCB-LTD
45  2019 Alcohol-induced conditioned place preference is modulated by CB2 cannabinoid receptors and modifies levels of endocannabinoids in the mesocorticolimbic system. AEA, CB2R, CPP
46  2019 Altered mRNA Expression of Genes Involved in Endocannabinoid Signalling in Squamous Cell Carcinoma of the Oral Tongue. SCCOT
47  2019 Brain region-dependent changes in the expression of endocannabinoid-metabolizing enzymes in rats following antidepressant drugs. DAGLalpha, FAAH, MAGL, NAPE-PLD
48  2019 Cannabinoid receptor-mediated modulation of inhibitory inputs to mitral cells in the main olfactory bulb. CB1, MOB
49  2019 Cannabis: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome. CB1R
50  2019 Circulating Endocannabinoids Are Reduced Following Bariatric Surgery and Associated with Improved Metabolic Homeostasis in Humans. 2-AG, AA, AEA, LSG, OEA, WC
51  2019 Countering the Modern Metabolic Disease Rampage With Ancestral Endocannabinoid System Alignment. CB1R, T2D
52  2019 Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place? FAAH, i.n, i.p
53  2019 Distinct functions of endogenous cannabinoid system in alcohol abuse disorders. ---
54  2019 Do Endocannabinoids Regulate Glucose Reabsorption in the Kidney? CB1R, DN, GLUT, RPTCs
55  2019 Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder. HAND
56  2019 Early life stress alters the developmental trajectory of corticolimbic endocannabinoid signaling in male rats. 2-AG, AEA, MS, PFC, PND2
57  2019 Endocannabinoid 2-arachidonoylglycerol is elevated in the coronary circulation during acute coronary syndrome. 2-AG, AEA, CAD, NSTEMI
58  2019 Endocannabinoid and Prostanoid Crosstalk inPain. 2-AG, AEA, COX, PG-EA, PG-G
59  2019 Endocannabinoid System and Alcohol Abuse Disorders. AUD, CB, CB1R, CB2R, CNS, Delta9-THC, FASD
60  2019 Endocannabinoids, stress signaling, and the locus coeruleus-norepinephrine system. LC, NE
61  2019 Expression of type I mGluRs predicts plasticity in the hippocampal stratum radiatum interneurons. LTD, mGluR5, STD
62  2019 Fatty acids and selected endocannabinoids content in cerebrospinal fluids from patients with neuroinfections. CSF, FA, VM
63  2019 Glucocorticoid interactions with the dorsal striatal endocannabinoid system in regulating inhibitory avoidance memory. CB1R
64  2019 Hemisphere-dependent endocannabinoid system activity in prefrontal cortex and hippocampus of the Flinders Sensitive Line rodent model of depression. 2-AG, AEA, CB1R, CNR1, FAAH, FRL, FSL, LC/MRM, MAGL
65  2019 Hypothalamic endocannabinoids inversely correlate with the development of diet-induced obesity in male and female mice. 2-AG, AEA, BAT, HFD
66  2019 Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa. 2-AG, ABA, AEA, AN, CB1R, OEA, PEA
67  2019 Loss of exercise- and stress-induced increases in circulating 2-arachidonoylglycerol concentrations in adults with chronic PTSD. 2-AG, AEA, OEA, PTSD
68  2019 Modulation of Endocannabinoid-Binding Receptors in Human Neuroblastoma Cells by Tunicamycin. FACS, qRT-PCR, TRPV1
69  2019 Multiple endocannabinoid-mediated mechanisms in the regulation of energy homeostasis in brain and peripheral tissues. ---
70  2019 Noradrenergic depletion causes sex specific alterations in the endocannabinoid system in the Murine prefrontal cortex. 2-AG, CB1r, DGLalpha, FAAH, MGL, NE, PFC, WT
71  2019 Pharmacological convergence reveals a lipid pathway that regulates C. elegans lifespan. ---
72  2019 Physiology of the Endocannabinoid System During Development. CBs
73  2019 Rapid and Concomitant Gut Microbiota and Endocannabinoidome Response to Diet-Induced Obesity in Mice. eCBome, HFHS
74  2019 Role of the endocannabinoid system in neurological disorders. ASD
75  2019 Role of the Endocannabinoidome in Human and Mouse Atherosclerosis. eCBome
76  2019 Serum Endocannabinoid and Mood Changes after Exercise in Major Depressive Disorder. AEA, MDD, MOD, PREF, TMD
77  2019 Species-specific susceptibility to cannabis-induced convulsions. 11-OH-THC, CB1 receptor, CBD
78  2019 Structural properties and role of the endocannabinoid lipases ABHD6 and ABHD12 in lipid signalling and disease. CNS
79  2019 Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies. CB1, CB2, PTSD
80  2019 The endocannabinoid system is affected by cholesterol dyshomeostasis: Insights from a murine model of Niemann Pick type C disease. 2-AG, AEA, NPC
81  2019 The Expanded Endocannabinoid System/Endocannabinoidome as a Potential Target for Treating Diabetes Mellitus. eCBome, T2D
82  2019 Trans-cinnamaldehyde shows anti-depression effect in the forced swimming test and possible involvement of the endocannabinoid system. FST, TCA
83  2018 Adolescent cannabinoid exposure effects on natural reward seeking and learning in rats. ACRS, NAc, PD, WIN
84  2018 Age-related regulation of bone formation by the sympathetic cannabinoid CB1 receptor. CB1, NE
85  2018 Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy. COX-2, eiC, FAAH, i.c, i.p, KA, MES, PEA, PTZ, TLE
86  2018 Brain endocannabinoid signaling exhibits remarkable complexity. ---
87  2018 Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials. CBD, PTSD
88  2018 Cannabinoids prevent depressive-like symptoms and alterations in BDNF expression in a rat model of PTSD. BDNF, FAAH, PFC, PTSD, SRs
89  2018 Characterization of the endocannabinoid system in subcutaneous adipose tissue in periparturient dairy cows and its association to metabolic profiles. 2-AG, AEA, AT, BW, MGLL, PP
90  2018 Dual Dopaminergic Regulation of Corticostriatal Plasticity by Cholinergic Interneurons and Indirect Pathway Medium Spiny Neurons. Chls, D2Rs, DA, iMSNs, LTD
91  2018 Effects of Cannabinoid Drugs on Aversive or Rewarding Drug-Associated Memory Extinction and Reconsolidation. 2-AG, CB1, CB2
92  2018 Effects of central RVD-hemopressin(alpha) administration on anxiety, feeding behavior and hypothalamic neuromodulators in the rat. CB, DA, HPLC, NE, POMC, RT-PCR
93  2018 Elevated levels of 2-arachidonoylglycerol promote atherogenesis in ApoE-/- mice. 2-AG, CB1, MAGL
94  2018 Endocannabinoid and Opioid System Interactions in Exercise-Induced Hypoalgesia. 2-AG, 2-OG, AEA, EIH, OEA, PEA
95  2018 Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism. 2-AG, AEA, HS, OEA, PBMCs, PEA, SLE
96  2018 Endocannabinoids modulate Gq/11 protein-coupled receptor agonist-induced vasoconstriction via a negative feedback mechanism. ---
97  2018 Endocannabinoids, exercise, pain, and a path to health with aging. ECS, PUFA
98  2018 Endogenous dopamine and endocannabinoid signaling mediate cocaine-induced reversal of AMPAR synaptic potentiation in the nucleus accumbens shell. eCBs, MSNs, NAc
99  2018 Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice. CB1R, EtOH, WIN
100  2018 Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens. CB1R, DA, FAAH, FSIs, MSNs, NAc, NAPE-PLD